These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 17654443)
21. Endothelial progenitor cells in vascular health: focus on lifestyle. Van Craenenbroeck EM; Conraads VM Microvasc Res; 2010 May; 79(3):184-92. PubMed ID: 20053364 [TBL] [Abstract][Full Text] [Related]
22. A novel hypothesis of atherosclerosis: EPCs-mediated repair-to-injury. Zhang M; Zhou SH; Li XP; Shen XQ; Fang ZF Med Hypotheses; 2008; 70(4):838-41. PubMed ID: 17920780 [TBL] [Abstract][Full Text] [Related]
23. Relationships between vascular dysfunction, circulating endothelial progenitor cells, and psychological status in healthy subjects. Chen H; Yiu KH; Tse HF Depress Anxiety; 2011 Aug; 28(8):719-27. PubMed ID: 21681866 [TBL] [Abstract][Full Text] [Related]
24. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Schmidt-Lucke C; Rössig L; Fichtlscherer S; Vasa M; Britten M; Kämper U; Dimmeler S; Zeiher AM Circulation; 2005 Jun; 111(22):2981-7. PubMed ID: 15927972 [TBL] [Abstract][Full Text] [Related]
25. Potential role of endothelial progenitor cells in the pathophysiology of heart failure: clinical implications and perspectives. Andreou I; Tousoulis D; Tentolouris C; Antoniades C; Stefanadis C Atherosclerosis; 2006 Dec; 189(2):247-54. PubMed ID: 16860805 [TBL] [Abstract][Full Text] [Related]
26. Challenges in vascular repair by endothelial progenitor cells in diabetic patients. António N; Fernandes R; Ribeiro CF; Providência LA Cardiovasc Hematol Disord Drug Targets; 2010 Sep; 10(3):161-6. PubMed ID: 20678063 [TBL] [Abstract][Full Text] [Related]
27. The endothelium and vascular inflammation in diabetes. Hartge MM; Unger T; Kintscher U Diab Vasc Dis Res; 2007 Jun; 4(2):84-8. PubMed ID: 17654441 [TBL] [Abstract][Full Text] [Related]
28. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance. Werner C; Kamani CH; Gensch C; Böhm M; Laufs U Diabetes; 2007 Oct; 56(10):2609-15. PubMed ID: 17623816 [TBL] [Abstract][Full Text] [Related]
29. The link between microalbuminuria, endothelial dysfunction and cardiovascular disease in diabetes. Naidoo DP Cardiovasc J S Afr; 2002; 13(4):194-9. PubMed ID: 12389063 [TBL] [Abstract][Full Text] [Related]
30. The pleiotropic effects of ARB in vascular endothelial progenitor cells. Matsuura K; Hagiwara N Curr Vasc Pharmacol; 2011 Mar; 9(2):153-7. PubMed ID: 21143169 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus. Hamilton SJ; Chew GT; Watts GF Diab Vasc Dis Res; 2007 Jun; 4(2):89-102. PubMed ID: 17654442 [TBL] [Abstract][Full Text] [Related]
32. The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review. Reddy KJ; Singh M; Bangit JR; Batsell RR J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):633-47. PubMed ID: 20164784 [TBL] [Abstract][Full Text] [Related]
34. Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes. Mishra M; Kumar H; Bajpai S; Singh RK; Tripathi K Diabetes Res Clin Pract; 2011 Nov; 94(2):255-61. PubMed ID: 21855158 [TBL] [Abstract][Full Text] [Related]
35. Endothelial progenitor cells as a new agent contributing to vascular repair. Miller-Kasprzak E; Jagodziński PP Arch Immunol Ther Exp (Warsz); 2007; 55(4):247-59. PubMed ID: 17659378 [TBL] [Abstract][Full Text] [Related]
36. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Cersosimo E; DeFronzo RA Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274 [TBL] [Abstract][Full Text] [Related]
37. AMPK activation as a strategy for reversing the endothelial lipotoxicity underlying the increased vascular risk associated with insulin resistance syndrome. McCarty MF Med Hypotheses; 2005; 64(6):1211-5. PubMed ID: 15823720 [TBL] [Abstract][Full Text] [Related]